305 related articles for article (PubMed ID: 21068087)
1. Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension.
Prieto MC; Williams DE; Liu L; Kavanagh KL; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F581-8. PubMed ID: 21068087
[TBL] [Abstract][Full Text] [Related]
2. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
[TBL] [Abstract][Full Text] [Related]
3. Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Milani CJ; Kobori H; Mullins JJ; Mitchell KD
Am J Med Sci; 2010 Nov; 340(5):389-94. PubMed ID: 20724906
[TBL] [Abstract][Full Text] [Related]
4. AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.
Williams DE; Prieto MC; Mullins JJ; Navar LG; Mitchell KD
Am J Med Sci; 2010 Apr; 339(4):356-61. PubMed ID: 20224314
[TBL] [Abstract][Full Text] [Related]
5. Direct renin inhibition with aliskiren normalizes blood pressure in Cyp1a1-Ren2 transgenic rats with inducible angiotensin ii-dependent malignant hypertension.
Howard CG; Mullins JJ; Mitchell KD
Am J Med Sci; 2011 May; 341(5):383-7. PubMed ID: 21358304
[TBL] [Abstract][Full Text] [Related]
6. Transient induction of ANG II-dependent malignant hypertension causes sustained elevation of blood pressure and augmentation of the pressor response to ANG II in CYP1A1-REN2 transgenic rats.
Howard CG; Mullins JJ; Mitchell KD
Am J Med Sci; 2010 Jun; 339(6):543-8. PubMed ID: 20375689
[TBL] [Abstract][Full Text] [Related]
7. Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Graciano ML; Mouton CR; Patterson ME; Seth DM; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1858-66. PubMed ID: 17344186
[TBL] [Abstract][Full Text] [Related]
8. Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Graciano ML; Mitchell KD
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F60-9. PubMed ID: 21975872
[TBL] [Abstract][Full Text] [Related]
9. Renal functional responses to selective intrarenal renin inhibition in Cyp1a1-Ren2 transgenic rats with ANG II-dependent malignant hypertension.
Howard CG; Mitchell KD
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F52-9. PubMed ID: 21993885
[TBL] [Abstract][Full Text] [Related]
10. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone receptor antagonism alleviates proteinuria, but not malignant hypertension, in Cyp1a1-Ren2 transgenic rats.
Ortiz RM; Graciano ML; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1584-91. PubMed ID: 17715265
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension.
Patterson ME; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F205-11. PubMed ID: 17977909
[TBL] [Abstract][Full Text] [Related]
13. Activation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in rats.
Shao W; Seth DM; Prieto MC; Kobori H; Navar LG
Am J Physiol Renal Physiol; 2013 Mar; 304(5):F505-14. PubMed ID: 23303412
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tubuloglomerular feedback in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Mitchell KD; Mullins JJ
Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1210-6. PubMed ID: 16033920
[TBL] [Abstract][Full Text] [Related]
15. Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review.
Gonzalez AA; Prieto MC
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):191-200. PubMed ID: 25780059
[TBL] [Abstract][Full Text] [Related]
16. Role of Collecting Duct Renin in the Pathogenesis of Hypertension.
Gonzalez AA; Lara LS; Prieto MC
Curr Hypertens Rep; 2017 Aug; 19(8):62. PubMed ID: 28695400
[TBL] [Abstract][Full Text] [Related]
17. 20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Sedláková L; Kikerlová S; Husková Z; Červenková L; Chábová VČ; Zicha J; Falck JR; Imig JD; Kompanowska-Jezierska E; Sadowski J; Krátký V; Červenka L; Kopkan L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054426
[TBL] [Abstract][Full Text] [Related]
18. Evolving concepts on regulation and function of renin in distal nephron.
Prieto MC; Gonzalez AA; Navar LG
Pflugers Arch; 2013 Jan; 465(1):121-32. PubMed ID: 22990760
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats.
Jíchová Š; Doleželová Š; Kopkan L; Kompanowska-Jezierska E; Sadowski J; Červenka L
Am J Med Sci; 2016 Dec; 352(6):618-630. PubMed ID: 27916218
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.
Prieto MC; González-Villalobos RA; Botros FT; Martin VL; Pagán J; Satou R; Lara LS; Feng Y; Fernandes FB; Kobori H; Casarini DE; Navar LG
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F749-55. PubMed ID: 21209009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
